## Abstract ## BACKGROUND The authors evaluated the efficacy of chemotherapy combined with rituximab followed by highβdose therapy (HDT) plus autologous stem cell transplantation in patients with mantle cell lymphoma (MCL). ## METHODS This was a retrospective analysis of 34 patients who were tre
β¦ LIBER β¦
Oral integrity and salivary profile in myeloma patients undergoing high-dose therapy followed by autologous SCT
β Scribed by Avivi, I; Avraham, S; Koren-Michowitz, M; Zuckerman, T; Aviv, A; Ofran, Y; Benyamini, N; Nagler, A; Rowe, J M; Nagler, R M
- Book ID
- 109840550
- Publisher
- Nature Publishing Group
- Year
- 2008
- Tongue
- English
- Weight
- 174 KB
- Volume
- 43
- Category
- Article
- ISSN
- 0007-1188
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Chemotherapy with rituximab followed by
β
Catherine Thieblemont; Daciana Antal; Laurence Lacotte-Thierry; Vincent Delwail;
π
Article
π
2005
π
John Wiley and Sons
π
English
β 122 KB
High-dose therapy and autologous periphe
β
Massimo Martino; Giuseppe Console; Giuseppe Irrera; Giulia PraticΓ²; Caterina Ste
π
Article
π
2006
π
John Wiley and Sons
π
English
β 240 KB
π 2 views
## Abstract The recent development of reduced intensity conditioning and allotransplantation (RICT) has opened a new way to assure engraftment of donor cells while reducing early transplantβrelated mortality. We evaluated the combination of highβdose therapy and autologous peripheral blood stem cel
Complete remission after myeloablation w
β
Wiesmann, A; Einsele, H; Kanz, L; Dohmen, B M
π
Article
π
2005
π
Nature Publishing Group
π
English
β 87 KB
A prospective, randomized study of cryot
β
Maloney, D G; Press, O W; Bensinger, W; Lilleby, K; Garcia, P; Gooley, T; McDonn
π
Article
π
2006
π
Nature Publishing Group
π
English
β 115 KB